Entrada Therapeutics, Inc. (TRDA)
12.58
+0.96
(+8.26%)
USD |
NASDAQ |
Mar 06, 16:00
12.81
+0.23
(+1.83%)
After-Hours: 20:00
Entrada Therapeutics EPS Diluted (Quarterly) : -0.9414 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| EyePoint Plc | -0.8143 |
| Repligen Corp. | 0.2345 |
| Vertex Pharmaceuticals, Inc. | 4.651 |
| Kodiak Sciences, Inc. | -1.163 |
| Arcutis Biotherapeutics, Inc. | 0.1282 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -39.16M |
| Revenue (Quarterly) | 1.299M |
| Total Expenses (Quarterly) | 40.46M |
| Enterprise Value | 236.19M |
| Gross Profit Margin (Quarterly) | 31.79% |
| Profit Margin (Quarterly) | -3.01K% |
| Earnings Yield | -27.59% |
| Normalized Earnings Yield | -27.33 |